Combination Treatment with Irritant and Recombinant Interleukin 2 in the Peritoneal Cavity for Evoking Effective Anti‐tumor Activity: Generation of Lymphokine‐activated Killer Cells and Tumor‐specific Killer Cells

Meth A sarcoma, growing in the subcutaneous tissue of syngeneic BALB/c mice, regressed completely after an intraperitoneal (ip) injection of protease peptone (PP) (on day 6) followed by 2 ip administrations (on days 7 and 8) of human recombinant interleukin‐2 (IL‐2, 25 μg/day), whereas one such trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Uchida, Hiroyuki, Taniguchi, Kazuto, Nomoto, Kikuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 1990
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918044/
https://www.ncbi.nlm.nih.gov/pubmed/2114394
http://dx.doi.org/10.1111/j.1349-7006.1990.tb02584.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918044/
https://www.ncbi.nlm.nih.gov/pubmed/2114394
http://dx.doi.org/10.1111/j.1349-7006.1990.tb02584.x

Ejemplares similares